HLA SPREAD Data Visualization

Clear Filter

Show Entries

PMID	Allele	Disease	Population	Drug Names	SNP	Class
24861233	HLA-B*57	NA	Thai	rs3093726	rs2395029	unclassified
NA
24861233	HLA-B*57	NA	Thai	rs3093726	rs2395029	unclassified
NA
24861233	HLA-B*57	NA	Thai	rs3093726	rs2395029	positive
NA
26103897	HLA-B (HLA-B)	pyrose	NA	NA	NA	unclassified
hla-b and hla-c supratyping by pyrosequencing(r).
26103897	HLA-C (HLA-C)	pyrose	NA	NA	NA	unclassified
hla-b and hla-c supratyping by pyrosequencing(r).
29750609	HLA-B*58	pyrose	Chinese	NA	rs9263726	unclassified
snps were analyzed by pyrosequencing, and hla-b*58:01 was evaluated by sequencing-based techniques.
29750609	HLA-B*58	pyrose	Chinese	NA	rs9263726	unclassified
consistency between sequencing-based hla-b*58:01 testing and pyrosequencing-based rs9263726 testing was investigated in 262 individuals.
29750609	HLA-B*58	pyrose	Chinese	NA	rs9263726	unclassified
the kappa values between sequencing-based hla-b*58:01 testing and pyrosequencing-based rs9263726 testing were 0.96 (>0.75), demonstrating they were well coincident with each other.
30947260	HLA-DR (HLA-DR)	pyrose	African	progesterone	NA	unclassified
cervicovaginal microbiota was determined by 16s pyrosequencing; 44 genital cytokines were measured by luminex; and cervical t-cell activation/proliferation (ccr5, hla-dr, cd38, ki67) was measured by multiparametric flow cytometry.
32014011	HLA-DQB1 (HLA-DQB1)	pyrose	NA	NA	NA	negation
methylation differences within the hla region at hla-dqb1 were identified on hm450 but could not be confirmed with pyrosequencing.